Sun, Dec 28, 2014, 12:02 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Spectrum Pharmaceuticals, Inc. Message Board

  • imho_dyodd imho_dyodd Jul 13, 2014 12:43 AM Flag

    rootbound - what is your view of the management?

    1. Folotyn sales will double in a "few years"
    2. Zevalin will do $300m in a "few years" (first time said in 2010)
    3. Fusilev will grow (until Dec 2012 - coincidentally management done with selling their stock at hyped prices)
    Then 2 months later, Fusilev sales was forecast to be 40-50% lower. Forget growth,
    Management answers to analyst when asked the question. What will happen to Fusilev when generic leucovorin shortage ceases ? Fusilev sales will grow. It doesn't matter if one generic enters or two, Fusilev is pure and is shown to be safer than generic leucovorin.
    4. Hello suckers Apaz has failed p3. Don't get baited again. See the above 3 and judge for yourself

    SortNewest  |  Oldest  |  Most Replied Expand all replies
6.97+0.07(+1.01%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.